Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Pancreatic Neoplasms × Drug Therapy × Clear all

Phase

Phase NA 13 Phase 2 12 Phase 1 7 Phase 1/2 4 Phase 3 3 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Small Cell Lung Carcinoma 2 Sarcoma 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Sarcoma, Ewing 1 SCLC 1 Retinoblastoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Oligometastatic Disease 1 Neoplasms, Germ Cell and Embryonal 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Locally Advanced Resectable Rectal Cancer 1 Glioblastoma 1 Gestational Trophoblastic Disease 1 Gastrointestinal Neoplasms 1

Interventions

Gemcitabine 13 Fluorouracil 6 Irinotecan 4 Cisplatin 4 Oxaliplatin 3 Capecitabine 3 nimotuzumab 2 Taxes 2 Phytotherapy 2 Leucovorin 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 surufatinib 1 rubitecan 1 racemetyrosine 1 pertuzumab 1 methylnaltrexone 1 folfirinox 1 camrelizumab 1 Trastuzumab 1 Tranexamic Acid 1 Standard of Care 1 Sirolimus 1 Positron Emission Tomography Computed Tomography 1 Phenytoin 1 Paclitaxel 1 Neoadjuvant Therapy 1 NUC-1031 1 Mirtazapine 1 Methoxsalen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00785421 2015-01-08

PROSPECT

CONKO-Studiengruppe

Phase 2/3 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡